Conversion surgery for undifferentiated carcinoma with osteoclast-like giant cells of the pancreas: a case report
Authors:
Open Access
- 14 March 2022
- journal article
- case report
- Published by Springer Nature in Surgical Case Reports
- Vol. 8 (1) , 1-5
Abstract
Background: Undifferentiated carcinoma with osteoclast-like giant cells (UCOGCs) is a rare subtype of pancreatic cancer (PC), and its clinicopathological characteristics are still unclear. Herein, we report a case of initially unresectable UCOGC that was successfully resected after FOLFIRINOX therapy. Case presentation: A 63-year-old man was referred to us for evaluation of a pancreatic mass detected by computed tomography (CT) during a medical checkup. Computed tomography showed a 7.5-cm tumor located in the pancreatic head and body, which involved the common hepatic artery (CHA), gastroduodenal artery (GDA), and main portal vein (PV) with tumor thrombus. UCOGC was suspected by endoscopic ultrasonography-guided fine needle aspiration, and the patient was diagnosed with unresectable locally advanced pancreatic cancer. After ten cycles of FOLFIRINOX, the tumor size decreased to 3 cm and the tumor thrombus in the main portal trunk had disappeared in the follow-up CT scan. However, the patient experienced severe adverse drug reactions, including neutropenia and liver dysfunction. Therefore, we performed pancreatoduodenectomy with portal vein resection. The pathological diagnosis was UCOGC with a negative tumor margin. He was treated with FOLFIRINOX, and remains recurrence-free for 6 months after surgery. Conclusions: We experienced a case undergoing conversion surgery for unresectable UCOGC, which resulted in R0 resection. FOLFIRINOX could be a possible regimen to achieve conversion surgery for UCOGC.Keywords
This publication has 19 references indexed in Scilit:
- Osteoclast Giant Cell Tumor of Pancreas: A Case Report and Literature ReviewCureus, 2019
- Conversion surgery for initially unresectable pancreatic cancer: current status and unresolved issuesSurgery Today, 2019
- PD-1, PD-L1, and CD163 in pancreatic undifferentiated carcinoma with osteoclast-like giant cells: expression patterns and clinical implicationsHuman Pathology, 2018
- Huge and recurrent undifferentiated carcinoma with osteoclast-like giant cells of the pancreasQuantitative Imaging in Medicine and Surgery, 2018
- Complete resection of a huge pancreatic undifferentiated carcinoma with osteoclast-like giant cellsInternational Cancer Conference Journal, 2017
- Pancreatic undifferentiated carcinoma with osteoclast‐like giant cells is genetically similar to, but clinically distinct from, conventional ductal adenocarcinomaThe Journal of Pathology, 2017
- Undifferentiated Carcinoma With Osteoclastic Giant Cells of the PancreasAmerican Journal of Surgical Pathology, 2016
- Effective Use of Gemcitabine in the Treatment of Undifferentiated Carcinoma with Osteoclast-Like Giant Cells of the Pancreas with Portal Vein Tumor ThrombusInternal Medicine, 2012
- Immunohistochemical and Genetic Analysis of Osteoclastic Giant Cell Tumor of the PancreasPancreas, 2006
- Osteoclast-like giant cell tumor of the pancreasInternational Journal of Clinical Oncology, 2002